Stock Code
603707.SH
ABOUT
>
Company profile
Enterprise Culture
Early Warning System
BUSINESS
>
Commercialized Products
MEDIA
>
News in NKF
CONTACT
CH / EN
Home
>
MEDIA
>
News in NKF
>
Paclitaxel For Injection (Albumin Bound) approved by US FDA
2025-05-20
Paclitaxel For Injection (Albumin Bound) approved by US FDA
share
Return
Previous
King-Friend will meet you in CPHI Frankfurt!
Next
NKF's subsidiary Kindos's Mitoxantrone Injection gets FDA approval for marketing
Relevant recommendations
2025-12-05
NKF's Propofol Injectable Emulsion has been approved by the US FDA and is about to enter the US market!
2025-12-03
NKF's subsidiary Kindos's Dalbavancin for Injection gets FDA approval for marketing
2025-10-21
NKF sincerely invites global customers to gather at CPHI Europe to explore new opportunities for cooperation together!
2025-10-17
NKF attended the 25th anniversary celebration of GMS in Pakistan to deepen strategic cooperation
2025-08-04
NKF's subsidiary Kindos's Etoposide Injection gets FDA approval for marketing
